Ulcerative Colitis Market: Global Opportunity Analysis and Industry Forecast, 2021-2030
The global ulcerative colitis market was valued at $6.2 billion in 2020, and is projected to reach $10.8 billion by 2030, growing at a CAGR of 5.7% from 2021 to 2030.
Report Code : A03620 | Pages : 225 | Category : Life Sciences
Antibiotics Market: Global Opportunity Analysis and Industry Forecast, 2018 - 2025
Antibiotic is an antimicrobial substance, which combats bacterial infections and occasionally protozoan infections. In addition, they are used to cure several diseases such as strep throat, urinary tract ...
Report Code : A04710 | Pages : 282 | Category : Life Sciences
Phytosterols Market:
The global phytosterols market size is expected to reach $935 million by 2022 from $490 million in 2015 at a CAGR of 9.62% from 2016 to 2022. The ...
Report Code : A01518 | Pages : 98 | Category : Life Sciences
Cystic Fibrosis (CF) Therapeutics Market: Global Opportunity Analysis and Industry Forecast, 2019-2026
The global cystic fibrosis therapeutics market size was valued at $4,615.4 million in 2018 and is expected to reach $9,277.3 million by 2026, registering a CAGR of 9.2% from 2019 to 2026.
Report Code : A05134 | Pages : 187 | Category : Life Sciences
Asia-Pacific Microencapsulated Ingredients Market:
The Asia-Pacific microencapsulated ingredients market was valued at $120.59 million in 2018 and is estimated to reach $193.36 million by 2026, growing at a CAGR of 6.0% from 2019 to 2026.
Report Code : A05279 | Pages : 245 | Category : Materials and Chemicals
Enzymes Market: Global Opportunity Analysis and Industry Forecast, 2021-2031
The global enzymes market was valued at $5.8 billion in 2021, and is projected to reach $10.2 billion by 2031, growing at a CAGR of 6% from 2022 to 2031.
Report Code : A00579 | Pages : 350 | Category : Life Sciences
Antimalarial Drugs Market: Global Opportunity Analysis and Industry Forecast, 2019–2026
The global antimalarial drugs market accounted for $711,360 thousand in 2018 and is expected to reach $1,019,396 thousand by 2026, registering a CAGR of 4.6% from 2019 to 2026.
Report Code : A02427 | Pages : 193 | Category : Life Sciences
Pregabalin Market: Global Opportunity Analysis and Industry Forecast, 2023-2032
The global pregabalin market was valued at $1.6 billion in 2022, and is projected to reach $2.2 billion by 2032, growing at a CAGR of 3% from 2023 to 2032.
Report Code : A02320 | Pages : 289 | Category : Life Sciences
Antihyperlipidemic Drugs Market: Global Opportunity Analysis and Industry Forecast, 2019–2026
The global antihyperlipidemic drugs market accounted for $9,456 million in 2018, and is expected to reach $16,865 million by 2026, registering a CAGR of 7.5% from 2019 to 2026.
Report Code : A05919 | Pages : 184 | Category : Life Sciences
Specialty Enzymes Market: Global Opportunity Analysis and Industry Forecast, 2021-2031
The global specialty enzymes market was valued at $1.2 billion in 2021, and is projected to reach $2.2 billion by 2031, growing at a CAGR of 6.7% from 2022 to 2031.
Report Code : A00575 | Pages : 245 | Category : Life Sciences
